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Successful adaptation to starvation in mammals depends
heavily on the regulated mobilization of fatty acids from
triacylglycerols stored in adipose tissue. Although it has
 
long been recognized that cyclic AMP represents the critical
second messenger and hormone-sensitive lipase (HSL)*
 
the rate-determining enzyme for lipolysis, simple activation
of the enzyme has failed to account for the robust augmen-
tation of fatty release in response to physiological agonists.
 
In this issue, Sztalryd et al. (2003) provide convincing sup-
port to the notion that the subcellular compartmentalization
of lipase also regulates lipolysis, and, more importantly, that
proteins other than HSL are localized to the lipid droplet
and are indispensable for its optimal hydrolysis.
 
Triacylglycerol (TAG) exists as the most efficient macro-
molecule for the storage of calories for times of fasting or
 
increased energy demand. In recent years, however, researchers
 
have come to appreciate not only complexity in the regulation
 
of lipid mobilization and metabolism, but its importance to
processes other than the supply of nutrients during intervals
 
of meager food consumption or increased exercise. For example,
TAG lipolysis produces glycerol and fatty acids. The resulting
elevated circulating fatty acids are an exceptional candidate
for an etiological factor in Type 2 diabetes mellitus, by virtue
of their ability to promote insulin resistance in skeletal muscle.
In spite of its importance, the cell biology of adipocyte lipid
mobilization has received remarkably little attention, especially
considering the abundance of research devoted to under-
standing the mobilization of glycogen, another repository
for energy. As an illustration of this discrepancy, it is inter-
esting to note that, even though Edwin Krebs published a
seminal paper demonstrating the enhancement of lipolysis
and neutral lipase activity by exposure to PKA in the presence
of cyclic AMP, his Nobel Prize lecture does not make mention
of TAG hydrolysis (Corbin et al., 1970; Krebs, 1993).
What then accounts for this seeming slur on lipid metabo-
lism? It is, of course, difficult to be certain, although at least
two factors are likely to have contributed: (1) the inherent
difficulty in studying enzymatic reactions on lipophilic sub-
strates, and (2) the perception that the essential features of
the regulation of lipolysis were already elucidated. Over
twenty years ago, abundant data supported a model in
 
which 
 
 
 
-adrenergic agents lead to an increase in the intra-
cellular concentration of the cyclic AMP that activates PKA,
which in turn phosphorylates and stimulates HSL. Even the
precise amino acid residue modified was established in the
late 1980’s as S563, although more modern analyses have
suggested that S659 and S660 are the more important regu-
latory sites of PKA phosphorylation (Garton et al., 1988;
Anthonsen et al., 1998). However, the more troublesome
matter that was widely recognized but not generally studied
was the conspicuous lack of correlation between the activation
in vitro of HSL by PKA phosphorylation, which was 1.5–
2-fold, and the augmentation in fatty acid release in vivo, gen-
erally exceeding 50-fold. Such a discrepancy often presents
itself in the comparison of broken-to-intact cell regulatory
processes. In this case, an important clue was provided by
Hirsch and Rosen’s report that cyclic AMP-stimulated lipolysis
in cultured adipocytes was accompanied by a redistribution
of triglyceride lipase from the soluble to a particulate fraction,
affirmed a surprising eight years later by the immunologic
demonstration of HSL relocalization to the fat droplet in
primary rat adipocytes (Hirsch and Rosen, 1984; Egan et al.,
1992). From these and other studies emerged that idea that
not only was activation of HSL required for maximal lipolysis,
but also its translocation to substrate, the lipid droplet.
However, the simplest explanation, that exposure of the
enzyme’s substrate-binding face would be sufficient to promote
HSL redistribution, turns out not be the case. Perhaps the
clearest demonstration of this is the finding in the current
work by Sztalryd et al. (2003) that HSL in fat cells lacking
another critical component, the regulatory protein perilipin,
is incapable of translocating to the lipid droplet after increases
in cyclic AMP.
A number of years ago, evidence appeared indicating that
the interface between the lipid droplet and the cytoplasm was
not at all banal, but was instead characterized by an elaborate
network involving filaments and tubular structures (Novikoff
et al., 1980; Franke et al., 1987). Functional complexity has
been more difficult to establish. However, it turns out that the
most prominent phosphorylated protein in the cyclic AMP-
treated adipocyte, perilipin, is localized to the periphery of the
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lipid droplet in the basal state (Greenberg et al., 1991, 1993).
Perilipin, which has been detected only surrounding intracel-
lular neutral lipids, is expressed exclusively in adipocytes and
steroidogenic cells, in which HSL serves to catalyze the cyclic
AMP-driven hydrolysis of cholesterol esters to yield substrate
for steroid hormone biosynthesis. Perilipin itself contains six
canonical cyclic AMP phosphorylation sites, of which the
amino-terminal three appear most important for function
(Tansey et al., 2003). A dramatic illustration of the impor-
tance of perilipin is provided by the phenotype of mice defi-
cient in its expression (Martinez-Botas et al., 2000; Tansey et
al., 2001). These animals exhibit a reduced fat cell mass and
striking resistance to obesity, as well as elevation in basal lipol-
ysis. Nonetheless, they are severely impaired in their ability to
respond to 
 
 
 
-adrenergic stimulation by an appropriate eleva-
tion in circulating fatty acids. Perhaps most surprising is that
mice lacking perilipin are more crippled in regard to regula-
tion of fatty acid mobilization than those deficient in HSL
(Osuga et al., 2000; Haemmerle et al., 2002). The explana-
tion for these observations is clearly provided here using sev-
eral tissue culture systems. First, they confirm that adipocytes
prepared from perilipin null mice do indeed display elevated
basal lipolysis in addition to resistance to 
 
 
 
-adrenergic stimu-
lation. Next, they utilize CHO cells, which normally contain
neither HSL nor perilipin, to show that expression of the
former is not sufficient to confer full PKA-responsive lipolysis,
which instead requires the presence of both proteins. More-
over, lipolysis correlated well with translocation of HSL to the
lipid droplet, serving to emphasize not only the importance of
subcellular localization to TAG breakdown, but also the cru-
cial role of perilipin phosphorylation in the redistribution of
HSL. Interestingly, in the absence of perilipin, another related
protein, ADRP, coats the lipid droplet, but this seems incapa-
ble of either restraining lipolysis to a minimum nor allowing
HSL to migrate to the TAG in the presence of cyclic AMP.
The authors understandably conclude that perilipin is en-
dowed with at least two unique properties: the ability to pre-
vent hydrolysis of intracellular TAG under resting conditions,
but also to respond to its own phosphorylation by PKA by
granting neutral lipase access to the droplet. That the latter is,
at least in part, a consequence of modification of perilipin and
not solely due to HSL phosphorylation is indicated by the re-
sidual cyclic AMP-stimulated lipolysis in HSL null cells, and
its dependency on perilipin phosphorylation.
Nonetheless, all these important insights leave obscure the
process by which perilipin governs accessibility of TAG to li-
pases. Although the simplest idea would be that perilipin
serves as an initial docking site for HSL, its ability to accom-
modate other lipases suggests a more elegant explanation.
Sztalryd et al. suggest as an alternative mechanism that phos-
phorylated perilipin somehow modifies the TAG such that
it is more effectively presented as a substrate. The idea that
protein-phospholipid interactions can alter the shape of the
plasma membrane has long been considered plausible,
though how similar alterations could be accomplished for
neutral lipid remain recondite (Huttner and Schmidt,
2000). One possibility is that phosphorylated perilipin
merely disperses TAG allowing easier contact by lipase, al-
though even how this could occur is difficult to envision.
Ultimately, it seems that resolving the mechanism of peri-
 
lipin action will be hampered by the same obstacle that has
slowed the work on lipolysis: the difficulty of obtaining a
clear picture of the lipid substrate. Nonetheless, the work of
Sztalryd et al. bring us closer to understanding how fatty
acid mobilization is regulated in the fat cell.
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